Table 2.
Initial findings of COVID-19
| Characteristic | All (N=64) | Severe group (n=44) | Critical group (n=20) | P value |
|---|---|---|---|---|
| Gestational age at symptom onset (wk) | 29.9±5.8 | 29.9±6.3 | 29.7±4.6 | .899 |
| Symptom onset at <24 wk | 10 (15.6) | 10 (22.7) | 0 (0) | .024 |
| Symptom onset at <34 wk | 44 (68.8) | 29 (65.9) | 15 (75) | .47 |
| Symptom onset at <37 wk | 55 (85.9) | 36 (81.8) | 19 (95) | .16 |
| Gestational age at hospitalization (wk) | 30.7±5.7 | 30.8±6.2 | 30.6±4.5 | .898 |
| Initial negative testing | 2 (3) | 0 (0) | 2 (10) | .094 |
| Source of sample | ||||
| Nasopharyngeal | 63 (98) | 44 (100) | 19 (95) | .14 |
| BAL | 1 (2) | 0 (0) | 1 (5) | |
Data are presented as mean±standard deviation or n (%).
BAL, bronchoalveolar lavage; COVID-19, coronavirus disease 2019.
Pierce-Williams et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies. AJOG MFM 2020.